Hedge Fund - Propel Bio Management
Phathom Pharmaceuticals Inc. (PHAT)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q4 (2025-12-31) | $12,291,830 | 10.49% | 740,918 | $14.28 |
| 2 | 2025 - Q3 (2025-09-30) | $6,507,951 | 6.51% | 552,927 | $10.32 |
| 3 | 2025 - Q2 (2025-06-30) | $8,850,870 | 10.74% | 922,927 | $5.53 |
| 4 | 2025 - Q1 (2025-03-31) | $7,115,992 | 8.27% | 1,134,927 | $6.07 |
| 5 | 2024 - Q4 (2024-12-31) | $8,038,207 | 7.98% | 989,927 | $12.38 |
| 6 | 2024 - Q3 (2024-09-30) | $15,728,280 | 9.12% | 869,927 | $13.98 |
| 7 | 2024 - Q2 (2024-06-30) | $8,960,248 | 5.81% | 869,927 | $10.30 |
| 8 | 2024 - Q1 (2024-03-31) | $9,238,625 | 5.37% | 869,927 | $8.49 |
| 9 | 2023 - Q4 (2023-12-31) | $4,045,019 | 3.35% | 443,047 | $8.62 |
The displayed share prices are average quarterly stock market prices.
Hedge Fund Resource Center